COLAIANNI, GRAZIANA
 Distribuzione geografica
Continente #
NA - Nord America 7.054
AS - Asia 2.894
EU - Europa 2.508
SA - Sud America 748
AF - Africa 192
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 13.410
Nazione #
US - Stati Uniti d'America 6.941
SG - Singapore 1.264
IT - Italia 823
CN - Cina 732
BR - Brasile 638
SE - Svezia 435
HK - Hong Kong 356
RU - Federazione Russa 345
DE - Germania 242
VN - Vietnam 183
GB - Regno Unito 143
CI - Costa d'Avorio 139
UA - Ucraina 124
FI - Finlandia 109
FR - Francia 95
IN - India 77
ID - Indonesia 58
CA - Canada 53
MX - Messico 43
AR - Argentina 41
BE - Belgio 34
NL - Olanda 32
JP - Giappone 31
ES - Italia 27
PL - Polonia 27
TR - Turchia 26
BD - Bangladesh 24
ZA - Sudafrica 20
IE - Irlanda 18
IQ - Iraq 17
AE - Emirati Arabi Uniti 16
PK - Pakistan 15
CO - Colombia 14
EC - Ecuador 13
AT - Austria 11
IR - Iran 11
PY - Paraguay 11
SA - Arabia Saudita 11
KR - Corea 10
PE - Perù 10
AU - Australia 8
CL - Cile 8
CZ - Repubblica Ceca 8
LT - Lituania 8
UZ - Uzbekistan 8
EG - Egitto 7
MA - Marocco 7
MY - Malesia 7
VE - Venezuela 7
JM - Giamaica 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
KE - Kenya 5
OM - Oman 5
PH - Filippine 5
UY - Uruguay 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
IL - Israele 4
JO - Giordania 4
BY - Bielorussia 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 13.410
Città #
Ashburn 814
Fairfield 806
Singapore 648
Woodbridge 568
Chandler 455
Houston 432
Bari 370
Hong Kong 354
Nyköping 350
Cambridge 346
Seattle 343
Ann Arbor 305
Wilmington 279
Jacksonville 276
Beijing 239
Dallas 204
Abidjan 139
New York 116
Roxbury 106
Nanjing 105
Lawrence 97
Los Angeles 95
Munich 82
Des Moines 72
Brooklyn 66
Grumo Appula 66
Inglewood 58
Ho Chi Minh City 55
Santa Clara 52
Boardman 46
Jakarta 46
Princeton 43
São Paulo 43
Hanoi 41
Chicago 38
San Diego 37
Brussels 34
Buffalo 33
London 33
Trani 33
Milan 32
Shenyang 30
Rome 29
Tokyo 29
Jiaxing 28
Dearborn 26
Dong Ket 25
Helsinki 24
Redwood City 24
Rio de Janeiro 24
Warsaw 24
Frankfurt am Main 23
Mexico City 23
Nanchang 23
Hebei 22
Pune 22
The Dalles 21
Changsha 19
Montreal 19
Moscow 19
Noicattaro 18
San Francisco 18
Dublin 17
Orem 17
Paris 17
Poplar 17
Tianjin 17
Falls Church 16
Toronto 16
Turku 15
Columbus 14
Ankara 13
Atlanta 13
Council Bluffs 13
Zhengzhou 13
Brasília 12
Campinas 12
Guangzhou 12
Nuremberg 12
Chennai 11
Denver 11
Johannesburg 11
Phoenix 11
Stockholm 11
Belo Horizonte 10
Boydton 10
Charlotte 10
Salt Lake City 10
Salvador 10
Shanghai 10
Baghdad 9
Boston 9
Falkenstein 9
Haiphong 9
Mumbai 9
Ningbo 9
Orta Nova 9
Amsterdam 8
Ardabil 8
Guarulhos 8
Totale 9.295
Nome #
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission 247
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 193
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 192
Functions of vasopressin and oxytocin in bone mass regulation 192
The myokine irisin increases cortical bone mass 189
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 189
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus 182
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 177
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice 176
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 175
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin 170
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases 160
Irisin levels correlate with bone mineral density in soccer players 158
Sclerostin stimulates angiogenesis in human endothelial cells 152
Mechanisms involved in childhood obesity-related bone fragility 149
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 146
Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes 144
Irisin and musculoskeletal health 141
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand Translocate in the Nucleus to Enhance Osteoblast Transcription 140
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 139
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins 132
Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells 132
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 131
Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton 130
Monoclonal antibodies for treating osteoporosis 129
The effects of bone pâté on human osteoblasts cell cultures 128
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 128
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 126
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 124
A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives 124
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 123
null 120
Role of Irisin on the bone-muscle functional unit 119
Osteotropic Cancers: From Primary Tumor to Bone 116
Mechanisms of Altered Bone Remodeling in Multiple Myeloma 115
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis 114
In vitro osteoclastogenesis and bone resorption during spaceflight 113
Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts 111
THE ROLE OF LIGHT ON BONE REMODELING 109
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand translocate in the Nucleus to enhance Osteoblast Specific Transcription 108
Oxytocin is an Anabolic Bone Hormone 108
Dominant gender-non-specific direct regulation of osteoblasts and osteoclasts by the pituitary hormone oxytocin 106
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 106
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 105
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction 104
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 104
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 103
The effect of Irisin on bone cells in vivo and in vitro 103
Irisin for care and prevention of osteoporosis 102
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 101
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability 101
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 101
Oxytocin: an estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption 100
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 100
Myokine Irisin and Its Effects Linking Bone and Muscle Function 99
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 99
Effects of extracorporeal shock waves on murine calvaria osteoblastic cells 98
Skeleton and glucose metabolism: a bone-pancreas loop 98
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 98
The Role of LIGHT in Multiple Myeloma-Bone Disease 97
null 96
A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism 95
Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption 95
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 94
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 94
Irisin for care and prevention of osteoporosis 94
Oxytocin decreases bone resorption upregulating nitric oxide synthase isoforms 93
Increased osteoclast activity in the presence of increased homocysteine concentrations 91
LIGHT as regulator of bone homeostasis during osteolytic bone metastasis formation in non-small cell lung cancer patients 91
Lack of oxytocin retards osteoblast differentiation and bone formation 90
Anatomy and physiology of skeletal tissue: The bone cells 90
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 90
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 90
Human osteoclasts express oxytocin receptor 89
Irisin promotes growth, migration and matrix formation in human periodontal ligament cells 89
T cells support the osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease 88
In vitro bone resorption during Spaceflight 86
null 86
null 85
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 85
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 83
Increased osteoclast differentiation and bone resorption during space flight 83
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 82
Bone Cells 81
Anatomy and physiology of adipose tissue 81
Oxytocin Receptor Nuclear Translocation Could Be A Novel Mechanism Mediating Osteoblast Differentiation Induced By Oxytocin 79
Irisin and Secondary Osteoporosis in Humans 79
T cell-regulation of osteoclast formation and survival involving OPG/TRAIL interaction in an vitro model from human multiple myeloma 78
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 77
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 76
Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia 76
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 76
The myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues 75
Irisin, the novel myokine responsible for benefits of physical exercise on bone 73
null 73
null 71
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 70
Trascriptional activation of the oxytocin promoter by estroges requires an intanct MAP kinase pathway in osteoclasts and osteoblests: a novel non classical nuclear mechanism 70
Irisin for care and prevention of osteoporosis 70
null 69
Totale 11.209
Categoria #
all - tutte 57.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.072 0 0 0 0 0 108 161 233 196 180 108 86
2021/2022959 71 85 10 29 45 82 28 37 96 68 163 245
2022/20231.366 181 169 97 88 135 190 33 156 233 14 29 41
2023/2024660 57 97 32 57 83 145 35 23 21 34 15 61
2024/20252.730 147 30 177 89 62 297 403 221 108 197 340 659
2025/20263.196 857 331 560 592 653 203 0 0 0 0 0 0
Totale 13.890